How strong is the evidence
Nearly 80% of employers say GLP-1 use is a major cost driver for their company, per a May Business Group on Health survey
For instance, exenatide, the first GLP-1-analogue developed, demonstrated to promote human monocyte differentiation into alternatively activated M2 macrophages, leading to an increase in anti-inflammatory cytokines such as IL-10 while significantly reducing pro-inflammatory cytokines, including IL-6, TNF- and IL-1 ( Furthermore, GLP-1 has been hypothesised to act as a mediator between innate and adaptive immune responses
Chevron nails: a normal variant in the pediatric population
Individuals with chronic liver conditions sometimes use these injections to support liver detox, though scientific evidence remains limited as referenced by the American Academy of Dermatology and the National Institutes of Health
Wegovy is a highly effective weight loss medication especially when paired with lifestyle changes like dietary modifications and regular exercise